Global Pravastatin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Pravastatin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Pravastatin (marketed as Pravachol or Selektine) is a member of the drug class of statins, used in combination with diet, exercise, and weight loss for lowering cholesterol and preventing cardiovascular disease.
Pravastatin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pravastatin market is projected to reach US$ 835 million in 2029, increasing from US$ 547 million in 2022, with the CAGR of 6.2% during the period of 2024 to 2029. Demand from Adults and Children are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pravastatin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Pravastatin key manufacturers include Bristol-Myers Squibb, TEVA, SANDOZ, APOTEX, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Cipla Inc., Lupin Pharmaceuticals and Glenmark, etc. Bristol-Myers Squibb, TEVA, SANDOZ are top 3 players and held % sales share in total in 2022.
Pravastatin can be divided into 10mg Tablet, 20mg Tablet, 40mg Tablet and 80mg Tablet, etc. 10mg Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Pravastatin is widely used in various fields, such as Adults and Children, etc. Adults provides greatest supports to the Pravastatin industry development. In 2022, global % sales of Pravastatin went into Adults filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pravastatin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bristol-Myers Squibb
TEVA
SANDOZ
APOTEX
Dr. Reddy's Laboratories
Zydus Pharmaceuticals
Cipla Inc.
Lupin Pharmaceuticals
Glenmark
Mylan
Aurobindo Pharma
Accord Healthcare
Upsher-Smith Laboratories
Hisun
Jiangxi Boyaseehot Pharmaceutical
Shanghai Shyndec Pharmaceutical
Daiichi Sankyo
North China Pharmaceutical Group
Segment by Type
10mg Tablet
20mg Tablet
40mg Tablet
80mg Tablet
Adults
Children
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pravastatin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pravastatin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pravastatin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pravastatin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pravastatin introduction, etc. Pravastatin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Pravastatin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Pravastatin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pravastatin market is projected to reach US$ 835 million in 2029, increasing from US$ 547 million in 2022, with the CAGR of 6.2% during the period of 2024 to 2029. Demand from Adults and Children are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pravastatin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Pravastatin key manufacturers include Bristol-Myers Squibb, TEVA, SANDOZ, APOTEX, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Cipla Inc., Lupin Pharmaceuticals and Glenmark, etc. Bristol-Myers Squibb, TEVA, SANDOZ are top 3 players and held % sales share in total in 2022.
Pravastatin can be divided into 10mg Tablet, 20mg Tablet, 40mg Tablet and 80mg Tablet, etc. 10mg Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Pravastatin is widely used in various fields, such as Adults and Children, etc. Adults provides greatest supports to the Pravastatin industry development. In 2022, global % sales of Pravastatin went into Adults filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pravastatin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bristol-Myers Squibb
TEVA
SANDOZ
APOTEX
Dr. Reddy's Laboratories
Zydus Pharmaceuticals
Cipla Inc.
Lupin Pharmaceuticals
Glenmark
Mylan
Aurobindo Pharma
Accord Healthcare
Upsher-Smith Laboratories
Hisun
Jiangxi Boyaseehot Pharmaceutical
Shanghai Shyndec Pharmaceutical
Daiichi Sankyo
North China Pharmaceutical Group
Segment by Type
10mg Tablet
20mg Tablet
40mg Tablet
80mg Tablet
Segment by Application
Adults
Children
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pravastatin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pravastatin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pravastatin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pravastatin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pravastatin introduction, etc. Pravastatin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Pravastatin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.